Healthcare provider profile · identity verified

Amber R Stephens, M.D.

Family Practice · DUNEDIN, FL · NPI 1407991250

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	386	110
Rosuvastatin Calcium	Rosuvastatin Calcium	377	120
Amlodipine Besylate	Amlodipine Besylate	368	118
Atorvastatin Calcium	Atorvastatin Calcium	337	101
Lisinopril	Lisinopril	284	90
Losartan Potassium	Losartan Potassium	270	84
Omeprazole	Omeprazole	266	87
Albuterol Sulfate Hfa	Albuterol Sulfate	215	78
Fluticasone Propionate	Fluticasone Propionate	215	85
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	181	46
Gabapentin	Gabapentin	169	62
Prednisone	Prednisone	160	123
Duloxetine Hcl	Duloxetine Hcl	152	42
Pantoprazole Sodium	Pantoprazole Sodium	151	57
Eliquis	Apixaban	148	29
Hydrochlorothiazide	Hydrochlorothiazide	145	42
Metoprolol Succinate	Metoprolol Succinate	139	46
Trazodone Hcl	Trazodone Hcl	124	45
Furosemide	Furosemide	120	45
Ozempic	Semaglutide	120	22
Simvastatin	Simvastatin	116	35
Tamsulosin Hcl	Tamsulosin Hcl	116	37
Alprazolam	Alprazolam	114	27
Metformin Hcl	Metformin Hcl	113	39
Montelukast Sodium	Montelukast Sodium	113	36
Potassium Chloride	Potassium Chloride	104	36
Tramadol Hcl	Tramadol Hcl	102	39
Tizanidine Hcl	Tizanidine Hcl	96	44
Sildenafil Citrate	Sildenafil Citrate	91	23
Warfarin Sodium	Warfarin Sodium	90	11
Alendronate Sodium	Alendronate Sodium	89	34
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	88	23
Metoprolol Tartrate	Metoprolol Tartrate	88	32
Glipizide	Glipizide	86	28
Sertraline Hcl	Sertraline Hcl	86	34
Pravastatin Sodium	Pravastatin Sodium	85	26
Carvedilol	Carvedilol	83	25
Fluoxetine Hcl	Fluoxetine Hcl	81	23
Clopidogrel	Clopidogrel Bisulfate	79	29
Pregabalin	Pregabalin	79	22
Atenolol	Atenolol	70	17
Bupropion Xl	Bupropion Hcl	69	24
Lovastatin	Lovastatin	63	17
Escitalopram Oxalate	Escitalopram Oxalate	60	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	58	17
Doxycycline Monohydrate	Doxycycline Monohydrate	57	47
Oxycodone Hcl	Oxycodone Hcl	51	suppressed
Jardiance	Empagliflozin	48	17
Ondansetron Odt	Ondansetron	48	29
Xarelto	Rivaroxaban	44	13
Buspirone Hcl	Buspirone Hcl	42	17
Ciprofloxacin Hcl	Ciprofloxacin Hcl	42	36
Hydroxyzine Hcl	Hydroxyzine Hcl	41	19
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	41	suppressed
Donepezil Hcl	Donepezil Hcl	37	17
Vitamin D2	Ergocalciferol (Vitamin D2)	37	15
Azithromycin	Azithromycin	36	34
Spiriva Respimat	Tiotropium Bromide	36	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	35	34
Aripiprazole	Aripiprazole	34	14
Meloxicam	Meloxicam	34	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	33	suppressed
Allopurinol	Allopurinol	32	suppressed
Famotidine	Famotidine	32	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	32	suppressed
Ondansetron Hcl	Ondansetron Hcl	31	14
Lorazepam	Lorazepam	30	suppressed
Temazepam	Temazepam	30	suppressed
Testosterone Cypionate	Testosterone Cypionate	30	suppressed
Citalopram Hbr	Citalopram Hydrobromide	29	suppressed
Diazepam	Diazepam	29	suppressed
Hydralazine Hcl	Hydralazine Hcl	29	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	29	suppressed
Symbicort	Budesonide/Formoterol Fumarate	29	11
Fenofibrate	Fenofibrate	27	suppressed
Finasteride	Finasteride	27	suppressed
Folic Acid	Folic Acid	27	suppressed
Nystatin	Nystatin	27	12
Acyclovir	Acyclovir	26	suppressed
Baclofen	Baclofen	26	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	26	suppressed
Topiramate	Topiramate	26	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	24	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	24	20
Pioglitazone Hcl	Pioglitazone Hcl	24	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	24	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	24	21
Diclofenac Sodium	Diclofenac Sodium	23	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Repatha Syringe	Evolocumab	22	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	16
Valacyclovir	Valacyclovir Hcl	22	15
Ventolin Hfa	Albuterol Sulfate	22	suppressed
Bumetanide	Bumetanide	21	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	21	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	20	suppressed
Glipizide Er	Glipizide	20	suppressed
Metformin Hcl Er	Metformin Hcl	20	suppressed
Mupirocin	Mupirocin	20	13
Nitroglycerin	Nitroglycerin	20	16
Prolia	Denosumab	20	12
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Mounjaro	Tirzepatide	19	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	19	suppressed
Methotrexate	Methotrexate Sodium	18	suppressed
Methylprednisolone	Methylprednisolone	18	18
Ofloxacin	Ofloxacin	18	15
Trulicity	Dulaglutide	18	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	17	suppressed
Ibuprofen	Ibuprofen	17	suppressed
Jantoven	Warfarin Sodium	17	suppressed
Sucralfate	Sucralfate	17	14
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Novolog Flexpen	Insulin Aspart	16	suppressed
Cephalexin	Cephalexin	15	14
Clonazepam	Clonazepam	15	suppressed
Fluconazole	Fluconazole	15	11
Ipratropium Bromide	Ipratropium Bromide	15	suppressed
Methocarbamol	Methocarbamol	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Ibandronate Sodium	Ibandronate Sodium	14	suppressed
Irbesartan	Irbesartan	14	suppressed
Midodrine Hcl	Midodrine Hcl	14	suppressed
Mirtazapine	Mirtazapine	14	suppressed
Celecoxib	Celecoxib	13	suppressed
Labetalol Hcl	Labetalol Hcl	13	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Xtampza Er	Oxycodone Myristate	13	suppressed
Amiodarone Hcl	Amiodarone Hcl	12	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Ciclopirox	Ciclopirox	12	suppressed
Estradiol	Estradiol	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Benzonatate	Benzonatate	11	suppressed
Fluocinonide	Fluocinonide	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Spironolactone	Spironolactone	11	suppressed
Synthroid	Levothyroxine Sodium	11	suppressed
Testosterone	Testosterone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error